Retina World Congress: A case based approch to using #Vabysmo

Just because Retina World Congress ended doesn’t mean the education does! We are recapping one of the Industry Expert Theaters presented by Maria H Berrocal MD and Dr. Baruch D. Kuppermann titled “A Case-Based Approach to using VABYSMO” #Vabysmo is the first and only FDA-approved treatment designed to block 2 causes of vision loss (VEGF and Ang-2) According to Dr. Berrocal, VABYSMO (faricimab-svoa) unlike Anti-VEGF agents alone, achieves greater drying effects than other agents. In addition, close to 80% of patients in both the #DME and #nAMD patients, we able to be treated every 3-4 months. Listen to this video to hear the rest of the highlights from Dr. Berrocal and Dr. Kupperman. #retina Retina World Congress Healio | Ocular Surgery News Vindico Medical Education #retinaworldcongress Financial Disclosures: Dr. Berrocal and Dr. Kuppermann are consultants for Genentech